New KCC City Clinic —  New Baneshwor → is now open.

KCC Brachytherapy Clinic

Research, publications
and international recognition.

KCC's brachytherapy programme publishes its outcomes, presents at international conferences, and contributes to evidence that other centres use. This page is for clinicians, researchers, and anyone who wants the detail.

Peer-reviewed publications

Published. Pubmed Indexed. .

All publications are indexed in PubMed. These are original outcome data from KCC's own patient series.

Radiation Oncology Journal · 2025

HDR interstitial brachytherapy for lip and buccal mucosa carcinoma: technique, outcomes, and cosmetic results

Pandit S, Sapkota S, Adhikari A, Yadav D, Yogal R et al. · Kathmandu Cancer Center

Key findings

100% local control across all patients at a median follow-up of 29 months. 77% of cases rated as having good cosmetic outcomes by independent expert review. All procedures performed under local anaesthesia — including patients in their nineties with significant comorbidities who would not have tolerated surgery or general anaesthesia.

This is the first published outcomes series for image guided lip and buccal mucosa brachytherapy from Nepal. It establishes that interstitial HDR brachytherapy is both feasible and effective at a resource-appropriate centre outside a high-income setting — and that cosmetic preservation is achievable without surgery for this cancer site.

PubMed indexed Korean Society for Radiation Oncology
Read article

Brachytherapy · American Brachytherapy Society

CT-guided HDR interstitial brachytherapy for lung lesions: feasibility and outcomes in a resource-limited setting

Sapkota S, Pandit S et al. · Kathmandu Cancer Center

Key findings

Feasibility and outcome data for CT-guided interstitial brachyablation — a single high-dose fraction delivered directly into the lung tumour — for both primary lung lesions and oligometastatic disease. KCC is among a handful of centres in South Asia performing this procedure.

Lung brachyablation requires interventional radiology expertise, a dedicated radiation oncology team, and real-time CT guidance. It is rarely offered outside high-volume centres in the USA, Europe, and a small number of Asian institutions. This paper demonstrates that the procedure can be safely performed outside that traditional context.

Best Paper · IBSCON 2025 · Indian Brachytherapy Society
American Brachytherapy Society
View on PubMed

Journal of Contemporary Brachytherapy

Interstitial brachytherapy for internal mammary lymph node involvement in breast cancer: a case report

Co-author: Pandit S · PMID: 37425203

Clinical significance

A novel application of interstitial brachytherapy to a clinically challenging site — the internal mammary chain — that is difficult to irradiate adequately with external beams without significant cardiac or pulmonary dose. Documents technique and feasibility as a case report.

PubMed indexed PMID: 37425203
View on PubMed

Ongoing study

Prospective research underway at KCC

Prospective study · Tongue cancer · KCC Tathali

HyBIRT — Hybrid Brachytherapy followed by IMRT

HyBIRT is a prospective study evaluating the combination of interstitial brachytherapy with intensity-modulated external radiotherapy for tongue cancer — specifically in patients who are not suitable for surgery or who choose not to have it. The hypothesis is that delivering a high local dose via brachytherapy, followed by target-volume coverage with IMRT, offers better local control than either modality alone while preserving speech and swallowing function.

Patient recruitment and follow-up are ongoing. Results will be submitted for publication when the dataset matures.

Cancer site Tongue (oral tongue and base)
Study type Prospective observational
Institution Kathmandu Cancer Center, Tathali
Principal investigators Dr. Subhas Pandit · Dr. Simit Sapkota

International presentations

Where KCC has presented its work

A selection of international conferences where KCC's brachytherapy team has been invited to present — as keynote speakers, guest speakers, or award recipients.

2024

Curietherapy 2024 · Montréal, Canada

Guest Speaker

Curietherapy is the premier annual congress for brachytherapy and interventional radiotherapy worldwide, drawing specialists from Europe, North America, Asia, and beyond. KCC was invited as a guest speaker — presenting the programme's experience and outcomes to an international clinical audience.

Dr. Subhas Pandit

2024

ABG Annual Conference · Hobart, Australia

Keynote Presenters — Global Brachytherapy Session

The Australasian Brachytherapy Group's annual conference brings together brachytherapy specialists from Australia, New Zealand, and across the Asia-Pacific. KCC presented in the global brachytherapy session — the conference's own account described the session as "humbling and inspirational," noting that KCC's breadth of practice "reminds us of what is possible." The visit included time at Peter MacCallum Cancer Centre in Melbourne — one of the world's leading cancer centres.

Dr. Subhas Pandit · Dr. Simit Sapkota

2024

MESRO 2024 · Riyadh, Saudi Arabia

Award-winning presentation — non-surgical treatment of oral cancers .

Dr. Abish Adhikari presented KCC's experience using brachytherapy as definitive treatment for oral cancers — achieving high cure rates with better cosmetic and functional outcomes than surgery. The talk received a conference award at MESRO 2024, the Middle East Society for Radiation Oncology's annual meeting.

Dr. Abish Adhikari

2025

IBSCON · Indian Brachytherapy Society Conference

Best Paper Award — CT-guided lung brachyablation Best Paper 2025

KCC's paper on CT-guided interstitial brachyablation for lung tumours was awarded best paper at IBSCON 2025. The Indian Brachytherapy Society conference is the largest dedicated brachytherapy meeting in South Asia and includes centres from across India, Nepal, Bangladesh, and Sri Lanka.

Dr. Subhas Pandit · Dr. Simit Sapkota

2023

IBSCON · Indian Brachytherapy Society Conference

Award — brachytherapy for soft palate and uvula cancer Award 2023

KCC's case report on brachytherapy for cancer of the soft palate and uvula — a technically unusual site with limited published data — received recognition at IBSCON 2023. Two consecutive IBSCON awards make KCC one of the most recognised programmes at South Asia's principal brachytherapy forum.

2025

FARO Webinar · 36th Edition

International Presenter — lung brachyablation

KCC presented its CT-guided HDR lung brachyablation technique and outcomes at the 36th edition of the FARO webinar series, reaching an international audience of radiation oncologists and brachytherapy specialists.

Dr. Subhas Pandit

2022

GHOS Conference

Great Horn Oncology Symposyum

KCC presented its brachytherapy procedure and results at GHOS 2022 event in Tanzania among African and International audience..

Dr. Subhas Pandit

Collaboration and referrals

For clinical collaboration, case referrals, or to discuss a specific patient, contact us directly.

WhatsApp Back to Brachytherapy
[email protected] +977-1-5091629